Cytori Cell Research Institute (TSE:3750) Net Income (Continuing Operations) : 円-889 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Cytori Cell Research Institute's Net Income (Continuing Operations) for the three months ended in Dec. 2023 was 円-109 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-889 Mil.

Cytori Cell Research Institute Net Income (Continuing Operations) Historical Data

The historical data trend for Cytori Cell Research Institute's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Net Income (Continuing Operations) Chart

Cytori Cell Research Institute Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

592.73

317.49

-775.45

-77.09

-1,059.73

Cytori Cell Research Institute Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-161.44	-337.03	-161.26	-281.67	-109.17

Cytori Cell Research Institute Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-889 Mil.

Cytori Cell Research Institute (TSE:3750) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Cytori Cell Research Institute Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytori Cell Research Institute (TSE:3750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

https://www.cytori.co.jp

Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines